[Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2].
Zeitz
M
M
Medizinische Klinik und Poliklinik, Klinikum Steglitz der FU Berlin.
D003131:Combined Modality Therapy; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000096:biosynthesis*; D017325:Hepatitis B Vaccines; D006801:Humans; D007117:Immunization, Secondary; D007376:Interleukin-2 / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000276:immunology / Q000628:therapy*; D010865:Pilot Projects; D006435:Renal Dialysis / Q000009:adverse effects; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000276:immunology
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D007376:Interleukin-2; D014761:Viral Hepatitis Vaccines
Hepatitis-B-Impfung bei Dialyse-patienten: Reversibilität der defekten Immunantwort durch gleichzeitige Gabe von Interleukin-2.